{"schema_version":"secwatch.filing_event.v1","accession":"0001785530-22-000020","form_type":"8-K","ticker":"HOWL","cik":"0001785530","company_name":"Werewolf Therapeutics, Inc.","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.309051+00:00","generated_at":"2026-06-25T21:53:44.903547+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Werewolf Therapeutics Q1 net loss $15.3M; Jazz Pharma license and $40M loan extend runway","bullets":["Net loss of $15.3M in Q1 2022 vs. $7.4M year-ago; R&D expense rose to $10.9M from $4.8M.","Cash and equivalents of $143.7M at March 31, 2022; plus Jazz $15M upfront and $20M loan tranche, runway through Q4 2023.","Entered exclusive global license with Jazz for WTX-613; $15M upfront, up to $1.26B milestones plus mid-single-digit royalties.","IND submissions for WTX-124 and WTX-330 on track; preclinical data presented at AACR 2022.","Closed $40M term loan with Pacific Western Bank; $20M available upon two IND acceptances by March 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001785530-22-000020","json":"https://secwatch.observer/filing/0001785530-22-000020.json","markdown":"https://secwatch.observer/filing/0001785530-22-000020.md","text":"https://secwatch.observer/filing/0001785530-22-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785530/000178553022000020/0001785530-22-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785530/000178553022000020/howl-20220510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:53:44.903547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}